Page last updated: 2024-08-26

bosentan anhydrous and n-oleoylethanolamine

bosentan anhydrous has been researched along with n-oleoylethanolamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edmunds, NJ; Woodward, B1
Edmunds, NJ; Lal, H; Woodward, B1

Other Studies

2 other study(ies) available for bosentan anhydrous and n-oleoylethanolamine

ArticleYear
Effects of tumour necrosis factor-alpha on the coronary circulation of the rat isolated perfused heart: a potential role for thromboxane A2 and sphingosine.
    British journal of pharmacology, 1998, Volume: 124, Issue:3

    Topics: Animals; Bosentan; Coronary Circulation; Endocannabinoids; Endothelin Receptor Antagonists; Ethanolamines; Heart; In Vitro Techniques; Indomethacin; Male; Myocardium; Oleic Acids; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Sphingosine; Sulfonamides; Thromboxane A2; Tumor Necrosis Factor-alpha; Vasoconstriction

1998
Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function.
    British journal of pharmacology, 1999, Volume: 126, Issue:1

    Topics: Animals; Antihypertensive Agents; Bosentan; Endocannabinoids; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Ethanolamines; Heart; Heart Rate; Heart Ventricles; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Nitroarginine; Oleic Acids; Perfusion; Pressure; Rats; Rats, Wistar; Sphingomyelin Phosphodiesterase; Stroke Volume; Sulfonamides; Temperature; Tumor Necrosis Factor-alpha; Ventricular Function; Ventricular Function, Left

1999